Theravance Biopharma, Inc.
NASDAQTheravance Biopharma enters July with a significant change in analyst sentiment — two firms cut to neutral on the same day, just as the stock's short score has been sliding lower for two weeks. The Street's pivot is the sharpest signal this week. On June 29, both Jones Trading and BTIG downgraded TBPH to neutral from buy, stripping the stock of its remaining bullish voices on the…
Snapshot as of 7 Jul 2026
Theravance Biopharma enters July with a significant change in analyst sentiment — two firms cut to neutral on the same day, just as the stock's short score has been sliding lower for two weeks. The Street's pivot is…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for TBPH — free to start on ORTEX.
Sign up for free →Open TBPH on ORTEX